BMY Chart BMY data by YCharts

Bristol Myers Squibb ( BMY)

Background: Bristol-Myers Squibb, a biopharmaceutical company, engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products that help patients prevail over serious diseases worldwide. The company was founded in 1887 and is headquartered in New York City.

52-Week Range: $30.10 to $36.34

Book Value: $9.59

Price to Book: 3.6

Earnings Payout Percentage: 49%

The company currently pays $1.36 per share in dividends for a fat yield of 4%. I reviewed back to the 1970s and the regular dividend is like the energizer bunny, it keeps going and going higher.

BMY Dividend Chart BMY Dividend data by YCharts

Shares are slowly but steadily climbing in the last 30 days. Shares are now 2.1% higher than last month.

The stock appreciated slightly last year, but not enough to be considered noise on the chart. Bristol-Myers climbed 1% in the last year. The average analyst target price for Bristol Myers Squibb is $34.47, and if analysts begin raising their price targets since "we are here."

If you liked this article you might like

CEOs Are Dropping Like Flies

How To Get a Promotion Using Legendary Former GE Head Jack Welch's Strategies

GE Nearing Deal to Sell Industrial Solutions Unit to Swiss-Based ABB

How to Fire People Like Former General Electric CEO Jack Welch

Tax Reform Is Coming and That Means Trump Stock Rally Is Ready to Kill It Again